He said he’s made it the aim of his research to develop ways of treating OSA with something other than a CPAP machine. “I don’t think CPAP is the be-all-end-all,” he said. “I spend most of my time in clinic helping patients who are intolerant to CPAP.”
The Role of Genetics
Leila Kheirandish-Gozal, MD, director of clinical sleep research in the department of pediatrics at the University of Chicago Pritzker School of Medicine, said the emergence of two new therapies for children with OSA is encouraging.
A different approach is required for OSA in children, because it is associated with increased inflammation in the upper airway as well as systemic inflammation and has its peak incidence between ages 2 and 8. It can also have long-lasting neurobehavioral, cardiovascular, metabolic and somatic growth consequences, Dr. Kheirandish-Gozal said.